Lataa...
Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis
INTRODUCTION: Juvenile idiopathic arthritis (JIA) is one of the most common chronic diseases with childhood onset. It comprises different subtypes of which the systemic onset subtype is often resistant to treatment. With the advent of biological treatment with tumor necrosis factor-α (TNFα)-inhibito...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2899792/ https://ncbi.nlm.nih.gov/pubmed/20694074 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|